DURHAM, N.C. – The Duke-Margolis Center for Health Policy recently gathered several experts to form recommendations on accelerating the use of mHealth technologies for research on medical treatments.
“There is not yet a clear path for how mHealth technologies can reliably and efficiently elicit, validate and transmit relevant data, and such data are currently not being collected on a sustained and longitudinal basis,” wrote the authors of the recently released report, “Mobilizing mHealth Innovation for Real-World Evidence Generation.”
The aim of the working group of experts from throughout the health care and mHealth ecosystem was to create collaborations between the patient, clinical and research communities, and mHealth companies to advance the science on collecting and using mHealth data for evidence generation.
The group made several recommendations in its report, including:
- Establish a learning research community to advance the development and use of patient/consumer-facing mHealth technologies in evidence generation;
- Ensure efficient access to well-characterized, standardized and robust user-generated health data; and
- Use mHealth to promote easier participation in research through the awareness of and adoption of standardized approaches for informed consent and patient privacy.
“Mobile health data for novel real-world evidence generation have the potential to transform health care,” wrote the report’s authors. “The steps described here can help harness the power of mHealth to achieve this transformation while balancing the needs of the patient/consumer, researchers and the mHealth companies in a responsible, ethical and empowering way.”